ArmoLIPID PLUS

ArmoLIPID PLUS is a widely recognized food supplement specifically designed to help maintain healthy cholesterol levels and support cardiovascular function. Developed originally by the Italian company Rottapharm Madaus, the brand has built a strong reputation based on its formula containing red yeast rice, berberine, and policosanols.

The brand has undergone significant corporate shifts in ownership over the last decade. Rottapharm was acquired by the Swedish pharmaceutical giant Meda AB in 2014, which was subsequently acquired by Viatris (formerly Mylan) in 2016. Today, the brand is managed globally under the Viatris umbrella, a leading American healthcare company. Despite its international ownership, the product continues to be primarily manufactured in Italy, maintaining its heritage and high standard of Mediterranean pharmaceutical production.